HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans

Head and Neck

Volumn 32, Issue 5, 2010, Pages 562-567

  Maxwell, Jessica H ^a,b   Kumar, Bhavna ^c,d   Feng, Felix Y ^c   McHugh, Jonathan B ^c   Cordell, Kitrina G ^c   Eisbruch, Avraham ^c   Worden, Francis P ^c   Wolf, Gregory T ^b   Prince, Mark E ^c   Moyer, Jeffrey S ^c   Teknos, Theodoros N ^c,d   Chepeha, Douglas B ^c   Stoerker, Jay ^e,f   Walline, Heather ^e,f   Carey, Thomas E ^c   Bradford, Carol R ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e SensiGen LLC   (United States)

^f SEQUENOM INC   (United States)

Author keywords

Epstein Barr virus; Human papillomavirus; Nasopharyngeal carcinoma; White North Americans

Indexed keywords

CARBOPLATIN; DOCETAXEL; PROTEIN P16; VIRUS RNA;

ADULT; AGED; ARTICLE; BIOPSY; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; DISTANT METASTASIS; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; OROPHARYNX CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CARCINOMA, SQUAMOUS CELL; EPSTEIN-BARR VIRUS INFECTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HERPESVIRUS 4, HUMAN; HUMANS; MICHIGAN; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77951612617     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21216     Document Type: Article

References (25)

1. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-1777.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005;365:2041-2054.
4. Dickson RI, Flores AD. Nasopharyngeal carcinoma: an evaluation of 134 patients treated between 1971-1980. Laryngoscope 1985;95:276-283.
5. SEER Cancer Statistics Review - Table I-4: Age-adjusted SEER incidence and U.S. death rates and 5-year relative survival rates by primary cancer site, sex and time period all races; Survival (1996-2004). In: SEER Cancer Statistics Review 1975-2005; National Cancer Institute.
6. SEER Cancer Statistics Review - Table I-8: SEER Incidence and U.S. Mortality Trends by Primary Cancer Site and Sex, Whites 1996-2005, U.S. Mortality, APC. In: SEER Cancer Statistics Review 1975-2005; National Cancer Institute.
7. Punwaney R, Brandwein MS, Zhang DY, et al. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein - Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction. Head Neck 1999;21:21-29. (Pubitemid 29006452)
8. Rassekh CH, Rady PL, Arany I, et al. Combined Epstein-Barr virus and human papillomavirus infection in nasopharyngeal carcinoma. Laryngoscope 1998;108:362-367.
9. Tung YC, Lin KH, Chu PY, Hsu CC, Kuo WR. Detection of human papilloma virus and Epstein-Barr virus DNA in nasopharyngeal carcinoma by polymerase chain reaction. Kaohsiung J Med Sci 1999;15:256-262.
10. Tyan YS, Liu ST, Ong WR, Chen ML, Shu CH, Chang YS. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors. J Clin Microbiol 1993;31:53-56.
11. Giannoudis A, Ergazaki M, Segas J, et al. Detection of Epstein-Barr virus and human papillomavirus in nasopharyngeal carcinoma by the polymerase chain reaction technique. Cancer Lett 1995;89:177-181.
12. Hørding U, Nielsen HW, Daugaard S, Albeck H. Human papillomavirus types 11 and 16 detected in nasopharyngeal carcinomas by the polymerase chain reaction. Laryngoscope 1994;104(1 Pt 1):99-102.
13. Kim SH, Koo BS, Kang S, et al. HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer 2007;120:1418-1425.
14. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006;24:2606-2611.
15. Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8:3187-3192. (Pubitemid 35155029)
16. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 2007;110:1429-1435.
17. Tran N, Rose BR, O'Brien CJ. Role of human papillomavirus in the etiology of head and neck cancer. Head Neck 2007;29:64-70.
18. Yang H, Yang K, Khafagi A, et al. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A 2005;102:7683-7688.
19. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol 2008;26:3138-3146.
20. Franchi A, Moroni M, Massi D, Paglierani M, Santucci M. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol 2002;26:1597-1604.
21. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
22. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008;26:3128-3137.
23. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527. (Pubitemid 36159887)
24. Lehr EE, Qadadri B, Brown CR, Brown DR. Human papillomavirus type 59 immortalized keratinocytes express late viral proteins and infectious virus after calcium stimulation. Virology 2003;314:562-571.
25. Spartz H, Lehr E, Zhang B, Roman A, Brown DR. Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes. Virology 2005;336:11-25.